These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21710270)

  • 41. Index lesion characterization by (11)C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma.
    Hernández-Argüello M; Quiceno H; Pascual I; Solorzano JL; Benito A; Collantes M; Rodríguez-Fraile M; Pardo J; Richter JA
    Prostate; 2016 Jan; 76(1):3-12. PubMed ID: 26390847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
    Larbi A; Omoumi P; Pasoglou V; Michoux N; Triqueneaux P; Tombal B; Cyteval C; Lecouvet FE
    Eur Radiol; 2019 Aug; 29(8):4503-4513. PubMed ID: 30413957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
    Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
    Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anterior Prostate Cancer: Diagnostic Performance of T2-Weighted MRI and an Apparent Diffusion Coefficient Map.
    Shinmoto H; Tamura C; Soga S; Okamura T; Horiguchi A; Asano T; Kaji T
    AJR Am J Roentgenol; 2015 Aug; 205(2):W185-92. PubMed ID: 26204306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diffusion-weighted magnetic resonance imaging in painful bone metastases: Using quantitative apparent diffusion coefficient as an indicator of effectiveness of single fraction versus multiple fraction radiotherapy.
    Musio D; De Francesco I; Galdieri A; Marsecano C; Piciocchi A; Napoli A; De Felice F; Tombolini V
    Eur J Radiol; 2018 Jan; 98():1-6. PubMed ID: 29279145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of diffusion-weighted imaging (DWI) and MR spectroscopy (MRS) as early response biomarkers in cervical cancer patients.
    Rizzo S; Buscarino V; Origgi D; Summers P; Raimondi S; Lazzari R; Landoni F; Bellomi M
    Radiol Med; 2016 Nov; 121(11):838-846. PubMed ID: 27372708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity--a preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging.
    Horger M; Claussen C; Kramer U; Fenchel M; Lichy M; Kaufmann S
    Eur J Radiol; 2014 Sep; 83(9):1655-64. PubMed ID: 24972451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of apparent diffusion coefficient values in prostate diseases characterization on diffusion-weighted magnetic resonance imaging.
    Salvaggio G; Calamia M; Purpura P; Bartolotta TV; Picone D; Dispensa N; Lunetta C; Bruno A; Raso L; Salvaggio L; Lo Re G; Galia M; Simonato A; Midiri M; Lagalla R
    Minerva Urol Nefrol; 2019 Apr; 71(2):154-160. PubMed ID: 30421590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma.
    Gutzeit A; Doert A; Froehlich JM; Eckhardt BP; Meili A; Scherr P; Schmid DT; Graf N; von Weymarn CA; Willemse EM; Binkert CA
    Skeletal Radiol; 2010 Apr; 39(4):333-43. PubMed ID: 20205350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
    Liu X; Zhou L; Peng W; Wang C; Wang H
    Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diffusion-weighted whole-body MRI (virtual PET) in screening for osseous metastases].
    Barceló J; Vilanova JC; Riera E; Balliu E; Peláez I; Martí J; Villalón M; Ruscalleda N
    Radiologia; 2007; 49(6):407-15. PubMed ID: 18021670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer.
    Park SY; Kim CK; Park BK; Park W; Park HC; Han DH; Kim B
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):749-55. PubMed ID: 22154286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate.
    Sadinski M; Medved M; Karademir I; Wang S; Peng Y; Jiang Y; Sammet S; Karczmar G; Oto A
    Abdom Imaging; 2015 Oct; 40(7):2523-8. PubMed ID: 25805558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-resolution diffusion-weighted imaging of the prostate.
    Medved M; Soylu-Boy FN; Karademir I; Sethi I; Yousuf A; Karczmar GS; Oto A
    AJR Am J Roentgenol; 2014 Jul; 203(1):85-90. PubMed ID: 24951199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
    Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions.
    Avcu S; Koseoglu MN; Ceylan K; Bulut MD; Unal O
    Br J Radiol; 2011 Oct; 84(1006):875-82. PubMed ID: 21224296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diffusion-weighted imaging of prostate cancer on 3T MR: Relationship between apparent diffusion coefficient values and Ki-67 expression.
    Zhang J; Jing H; Han X; Huang Z; Cao Z; Liu Q
    Acad Radiol; 2013 Dec; 20(12):1535-41. PubMed ID: 24200480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
    Ryoo I; Kim JH; Choi SH; Sohn CH; Kim SC
    Magn Reson Med Sci; 2015; 14(4):337-45. PubMed ID: 26104081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.